Show simple item record

Flow cytometric analysis of cytologic specimens in hematologic disease Presented in part before the International Academy of Pathology, Washington, D.C., February 28-March 3, 1988 (Lab Invest 1988; S8:37A).

dc.contributor.authorHanson, Curtis A.en_US
dc.contributor.authorSchnitzer, Bertramen_US
dc.date.accessioned2006-04-28T17:02:45Z
dc.date.available2006-04-28T17:02:45Z
dc.date.issued1989en_US
dc.identifier.citationHanson, Curtis A.; Schnitzer, Bertram (1989)."Flow cytometric analysis of cytologic specimens in hematologic disease Presented in part before the International Academy of Pathology, Washington, D.C., February 28-March 3, 1988 (Lab Invest 1988; S8:37A). ." Journal of Clinical Laboratory Analysis 3(1): 2-7. <http://hdl.handle.net/2027.42/38530>en_US
dc.identifier.issn0887-8013en_US
dc.identifier.issn1098-2825en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/38530
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2715871&dopt=citationen_US
dc.description.abstractCytologic evaluation of body fluids and fine needle aspirations (FNA) is frequently required in patients with hematologic diseases. In this study we have correlated immunophenotyping and DNA analysis by flow cytometry with cytologic findings and tissue biopsies from 20 patients with body fluid specimens and 5 with FNA. Nineteen of 25 cases, including all FNA cases, had an immunophenotype consistent with malignancy: 12 monoclonal lymphomas, 2 T-cell lymphomas, 2 T-ALL and 3 non-T-ALL. By cytologic examination, 14 of these 19 cases were positive for malignant cells, 2 suspicious and 3 negative; the latter 5 cases, including 2 FNA cases, had small monoclonal B-cell populations detected by flow cytometry. Six cases had a benign immunophenotype; cytologic examination was benign in 4 of these and suspicious for lymphoma in 2. Our results show the feasibility of using flow cytometry to evaluate body fluids or FNA and demonstrate that small malignant populations that may be missed by routine cytology can be detected by flow cytometry.en_US
dc.format.extent528472 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherMicrobiology and Immunologyen_US
dc.titleFlow cytometric analysis of cytologic specimens in hematologic disease Presented in part before the International Academy of Pathology, Washington, D.C., February 28-March 3, 1988 (Lab Invest 1988; S8:37A).en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPathologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan ; Department of Pathology, University of Michigan Medical School, MS242 Medical Science I, Ann Arbor, MI 48109-00602en_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michiganen_US
dc.identifier.pmid2715871en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/38530/1/1860030103_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/jcla.1860030103en_US
dc.identifier.sourceJournal of Clinical Laboratory Analysisen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.